JPH10500704A - タンパクおよびペプチドのための安定化溶液 - Google Patents
タンパクおよびペプチドのための安定化溶液Info
- Publication number
- JPH10500704A JPH10500704A JP8527023A JP52702396A JPH10500704A JP H10500704 A JPH10500704 A JP H10500704A JP 8527023 A JP8527023 A JP 8527023A JP 52702396 A JP52702396 A JP 52702396A JP H10500704 A JPH10500704 A JP H10500704A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- troponin
- protein
- solution
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.a.緩衝剤; b.還元剤; c.安定化タンパク質; d.キレート剤;および e.塩 を含んでいるタンパク質およびタンパク質フラグメントまたは検体を安定化す るための液体組成物。 2.検体は心臓マーカーまたはそのフラグメントである請求項1の組成物。 3.検体はトロポニンまたはそのフラグメントである請求項1の組成物。 4.検体はトロポニンIまたはそのフラグメントである請求項1の組成物。 5.検体は である請求項1の組成物。 6.検体は である請求項1の組成物。 7.ブロッキング剤をさらに含んでいる請求項1の組成物。 8.増嵩剤をさらに含んでいる請求項1の組成物。 9.凍結乾燥されている請求項8の組成物。 10.凍結されている請求項1の組成物。 11.タンパク質安定化剤はアルブミンである請求項1の組成物。 12.アルブミンはプロテアーゼ不含である請求項11の組成物。 13.ブロッキング剤はゼラチンである請求項7の組成物。 14.増嵩剤は、トレハロース、グルコース、スクロース、ガラクトース、マンノ ース、マルトース、ラクトース、イソマルトース、セロビオース、マンノビオー ス、メルビオース、マルトトリオース、ナイストース、マルトテトラオース、マ ルトペンタオース、マルトヘキサオースおよびマルトヘプタオースよりなる群か ら選ばれる請求項8の組成物。 15.a.緩衝剤; b.N−アセチルシステイン、2−アミノエタンチオール、2−メルカプト エタノール、2−メルカプトエチルアニリンおよびジチオスレイトールよりなる 群から選ばれた還元剤; c.アルブミン、卵アルブミンおよびカゼインよりなる群から選ばれた安定 化タンパク質; d.エチレンビス(オキシエチレンニトリロ)テトラ酢酸(EGTA),エ チレンジアミンテトラ酢酸(EDTA),クエン酸塩またはシュウ酸塩よりなる 群から選ばれたキレート剤;および e.塩 を含んでいるタンパク質およびタンパク質フラグメントまたは検体を安定化す るための組成物。 16.ブロッキング剤をさらに含んでいる請求項15の組成物。 17.増嵩剤をさらに含んでいる請求項15の組成物。 18.凍結乾燥されている請求項17の組成物。 19.冷凍されている請求項15の組成物。 20.タンパク質安定化剤はアルブミンである請求項15の組成物。 21.アルブミンはプロテアーゼ不含である請求項20の組成物。 22.ブロッキング剤はゼラチンである請求項17の組成物。 23.増嵩剤はトレハロース、グルコース、スクロース、ガラクトース、マンノー ス、マルトース、ラクトース、イソマルトース、セロビオース、マンノビオース 、メルビオース、マルトトリオース、ナイストース、マルトテトラオース、マル トペンタオース、マルトヘキサオースおよびマルトヘプタオースよりなる群から 選ばれる請求項17の組成物。 24.タンパク質またはタンパク質フラグメントを安定化するための非ヒト血清系 水溶液を調製する方法であって 緩衝剤、還元剤、安定化タンパク質、キレート 剤および塩の有効量を溶液中で混合することを特徴とする前記方法。 25.緩衝剤、還元剤、安定化タンパク質、キレート剤および塩の有効量を溶液中 で混合することよりなる方法によって調製された、タンパク質またはタンパク質 フラグメントを安定化するための非ヒト血清系溶液。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/400,158 | 1995-03-07 | ||
US08/400,158 US6165981A (en) | 1995-03-07 | 1995-03-07 | Stabilizing solutions for proteins and peptides |
PCT/US1996/003034 WO1996027661A1 (en) | 1995-03-07 | 1996-03-06 | Stabilizing solutions for proteins and peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH10500704A true JPH10500704A (ja) | 1998-01-20 |
JP3740644B2 JP3740644B2 (ja) | 2006-02-01 |
Family
ID=23582452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52702396A Expired - Fee Related JP3740644B2 (ja) | 1995-03-07 | 1996-03-06 | タンパクおよびペプチドのための安定化溶液 |
Country Status (8)
Country | Link |
---|---|
US (1) | US6165981A (ja) |
EP (1) | EP0759074B1 (ja) |
JP (1) | JP3740644B2 (ja) |
AU (1) | AU698790B2 (ja) |
CA (1) | CA2189737A1 (ja) |
DE (1) | DE69600407T2 (ja) |
ES (1) | ES2121479T3 (ja) |
WO (1) | WO1996027661A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022501398A (ja) * | 2018-09-28 | 2022-01-06 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド | 精製ミュラー管抑制因子(mis)の安定化のための貯蔵溶液組成物ならびにそれに関連する使用方法および製造方法 |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627404B1 (en) * | 1995-04-18 | 2003-09-30 | Biosite, Inc. | Methods for improving the recovery of troponin I and T in membranes, filters and vessels |
US7006874B2 (en) * | 1996-01-05 | 2006-02-28 | Thermage, Inc. | Treatment apparatus with electromagnetic energy delivery device and non-volatile memory |
AU4160597A (en) * | 1996-08-23 | 1998-03-06 | Eli Lilly And Company | Protein formulations |
DE69713517D1 (de) * | 1996-10-15 | 2002-07-25 | Medical Analysis Systems Inc | Verfahren zur Stabilisierung von Troponin I (CTnI) durch Konjugation mit einem activen Polymer |
FR2756827B1 (fr) * | 1996-12-05 | 1999-01-29 | Pasteur Sanofi Diagnostics | Composes synthetiques biepitopiques utilisables comme etalons dans les dosages biologiques de la troponine i |
US6156521A (en) * | 1997-12-19 | 2000-12-05 | Biosite Diagnostics, Inc. | Methods for the recovery and measurement of troponin complexes |
EP0983091A4 (en) * | 1997-01-17 | 2002-04-10 | Lilly Co Eli | OBESITY PROTEIN COMPOSITION |
KR20000070338A (ko) * | 1997-01-20 | 2000-11-25 | 나가시마 카쭈시게, 노미야마 아키히코 | 펩티드의 안정화 방법 및 당해 방법을 이용한 펩티드 함유 동결건조 의약조성물 |
AU6569998A (en) * | 1997-03-20 | 1998-10-12 | Eli Lilly And Company | Obesity protein formulations |
US6248869B1 (en) | 1997-05-29 | 2001-06-19 | Medical Analysis Systems, Inc. | Troponin I forms and use of the same |
WO1998056900A1 (en) * | 1997-06-13 | 1998-12-17 | Medical Analysis Systems Inc. (Mas) | Stabilized compositions of cardiac markers |
WO2000023585A1 (en) | 1998-10-21 | 2000-04-27 | Spectral Diagnostics, Inc. | Cardiac troponin i polypeptide fragments and uses in diagnostics |
DE19930676B4 (de) | 1999-07-02 | 2006-01-19 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln |
FR2797689B1 (fr) | 1999-08-16 | 2003-06-27 | Pasteur Sanofi Diagnostics | Utilisation de composes synthetiques pour des immunodosages |
US7078486B2 (en) | 1999-12-10 | 2006-07-18 | Spectral Diagnostics, Inc. | Single-chain polypeptides comprising troponin I and troponin C |
WO2002017956A2 (en) * | 2000-08-31 | 2002-03-07 | Chiron Corporation | Stabilized fgf formulations containing reducing agents |
US6962700B1 (en) * | 2000-09-13 | 2005-11-08 | Atopix Pharmaceuticals Corporation | Method of manufacturing immune globulin |
US6538104B2 (en) | 2001-04-27 | 2003-03-25 | Medical Analysis Systems, Inc. | Stabilization of cardiac troponin I subunits and complexes |
US6927062B2 (en) * | 2002-11-25 | 2005-08-09 | Agdia, Inc. | Controls and standards for assays and method for manufacture thereof |
US7291501B2 (en) * | 2003-07-16 | 2007-11-06 | Abbott Laboratories | Stable compositions for measuring human natriuretic peptides |
US7445933B2 (en) * | 2003-07-16 | 2008-11-04 | Abbott Laboratories, Inc. | Stable calibrators or controls for measuring human natriuretic peptides |
US20050136542A1 (en) * | 2003-12-19 | 2005-06-23 | Beckman Coulter, Inc. | Stabilized liquid reference solutions |
DE602006013443D1 (de) * | 2005-04-28 | 2010-05-20 | Abbott Lab | Stabilisierung von herz-troponin |
AU2007234612B2 (en) | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
US7678764B2 (en) * | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
JP5323832B2 (ja) * | 2007-08-07 | 2013-10-23 | アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー | 酸性水溶液中にgdf−5を含むタンパク質製剤 |
CA2720845A1 (en) | 2008-04-14 | 2009-10-22 | Advanced Technologies And Regenerative Medicine, Llc | Liquid buffered gdf-5 formulations |
US20110306148A1 (en) | 2010-06-14 | 2011-12-15 | Siemens Healthcare Diagnostics Inc. | Composition for use as an assay reagent |
CN107167613B (zh) * | 2017-06-22 | 2018-10-02 | 深圳清华大学研究院 | 用于等离子体金芯片的蛋白点样缓冲液 |
CN109254153B (zh) * | 2018-08-27 | 2021-10-12 | 广东菲鹏生物有限公司 | 肌红蛋白的抗氧化剂及其应用 |
CN109725148B (zh) * | 2018-12-30 | 2022-05-03 | 广东环凯微生物科技有限公司 | 一种免疫磁珠保存液 |
AU2021260878A1 (en) | 2020-04-20 | 2022-11-17 | Vestaron Corporation | Proteolytically stable U1-agatoxin-Ta1b variant polypeptides for pest control |
AU2021265277A1 (en) | 2020-05-01 | 2022-12-08 | Vestaron Corporation | Insecticidal combinations |
CN114324882B (zh) * | 2020-10-12 | 2022-12-27 | 广东菲鹏生物有限公司 | 蛋白稳定剂及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4931385A (en) * | 1985-06-24 | 1990-06-05 | Hygeia Sciences, Incorporated | Enzyme immunoassays and immunologic reagents |
US5217890A (en) * | 1991-08-20 | 1993-06-08 | Eastman Kodak Company | Stabilized composition containing creatine kinase and protein having blocked sulfhydryl groups |
FR2701954B1 (fr) * | 1993-02-23 | 1995-07-07 | Pasteur Sanofi Diagnostics | Composition stabilisée de troponine pour immunoessais et procédé de stabilisation de troponine pour immunoessais. |
JPH09503050A (ja) * | 1993-05-17 | 1997-03-25 | フォートロン バイオサイエンス インク. | 心臓トロポニン▲i▼のアッセイ |
-
1995
- 1995-03-07 US US08/400,158 patent/US6165981A/en not_active Expired - Lifetime
-
1996
- 1996-03-06 DE DE69600407T patent/DE69600407T2/de not_active Expired - Lifetime
- 1996-03-06 EP EP96907187A patent/EP0759074B1/en not_active Expired - Lifetime
- 1996-03-06 ES ES96907187T patent/ES2121479T3/es not_active Expired - Lifetime
- 1996-03-06 WO PCT/US1996/003034 patent/WO1996027661A1/en active IP Right Grant
- 1996-03-06 CA CA002189737A patent/CA2189737A1/en not_active Abandoned
- 1996-03-06 JP JP52702396A patent/JP3740644B2/ja not_active Expired - Fee Related
- 1996-03-06 AU AU50929/96A patent/AU698790B2/en not_active Ceased
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022501398A (ja) * | 2018-09-28 | 2022-01-06 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド | 精製ミュラー管抑制因子(mis)の安定化のための貯蔵溶液組成物ならびにそれに関連する使用方法および製造方法 |
Also Published As
Publication number | Publication date |
---|---|
DE69600407D1 (de) | 1998-08-13 |
AU698790B2 (en) | 1998-11-05 |
CA2189737A1 (en) | 1996-09-12 |
AU5092996A (en) | 1996-09-23 |
EP0759074A1 (en) | 1997-02-26 |
EP0759074B1 (en) | 1998-07-08 |
US6165981A (en) | 2000-12-26 |
DE69600407T2 (de) | 1999-04-29 |
ES2121479T3 (es) | 1998-11-16 |
WO1996027661A1 (en) | 1996-09-12 |
JP3740644B2 (ja) | 2006-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH10500704A (ja) | タンパクおよびペプチドのための安定化溶液 | |
JP3357163B2 (ja) | 免疫学的測定用トロポニン安定化組成物および安定化法 | |
Glueck et al. | Hypofibrinolysis: a common, major cause of osteonecrosis | |
Hirzel et al. | Relationship between myosin isoenzyme composition, hemodynamics, and myocardial structure in various forms of human cardiac hypertrophy. | |
Urdal et al. | Cytoplasmic creatine kinase isoenzymes quantitated in tissue specimens obtained at surgery. | |
Kontos et al. | Use of the combination of myoglobin and CK-MB mass for the rapid diagnosis of acute myocardial infarction | |
Checchia et al. | Circulating cardiac troponin I levels in Kawasaki disease | |
Blann et al. | Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis | |
Marcovina et al. | Lipoprotein (a) and coronary heart disease risk | |
Deguchi et al. | Novel blood coagulation molecules: skeletal muscle myosin and cardiac myosin | |
JP5006037B2 (ja) | ヒトナトリウム利尿ペプチド測定用の安定な組成物 | |
Nossel et al. | Potential use of fibrinopeptide A measurements in the diagnosis and management of thrombosis | |
JPH10160734A (ja) | イムノアッセイ用較正/対照用配合物 | |
Quattrone et al. | A hypofibrinolytic state in overweight patients with cerebral venous thrombosis and isolated intracranial hypertension | |
JP3672672B2 (ja) | イムノアッセイ用のトロポニンの安定組成物およびそのような安定組成物の製法 | |
Nilsson et al. | Plasma thrombomodulin concentrations in relation to cardiovascular risk factors in a population sample | |
KATUS et al. | Myosin light chains release in acute myocardial infarction: non-invasive estimation of infarct size | |
JP2002511932A (ja) | 心臓マーカーの安定化組成物 | |
JP4033534B2 (ja) | ヒトヘモグロビンの安定化方法 | |
Stubbs et al. | A prospective study of the role of lipoprotein (a) in the pathogenesis of unstable angina | |
Clark et al. | Suppression of high-affinity ligand binding to the major glutathione S-transferase from Galleria mellonella by physiological concentrations of glutathione | |
Mól et al. | Risk factors of cardiac insufficiency in children with multisystem inflammatory syndrome and COVID-19: A prospective cohort study | |
EP1568782A1 (de) | Diagnose und Therapie von ADAMTS-13 assoziierten Erkrankungen | |
JP4321899B2 (ja) | 尿中ミオグロビンの安定化方法およびこれに用いる安定化剤 | |
Shah et al. | A serial follow up study of cardiac marker enzymes during the week after acute myocardial infarction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050719 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050830 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20051025 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20051027 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091118 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091118 Year of fee payment: 4 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091118 Year of fee payment: 4 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101118 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101118 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111118 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121118 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121118 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131118 Year of fee payment: 8 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |